A detailed history of Israel Englander (Millennium Management LLC) transactions in X Biotech Inc. stock. As of the latest transaction made, Millennium Management LLC holds 281,019 shares of XBIT stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
281,019
Previous 361,661 22.3%
Holding current value
$1.86 Million
Previous $1.86 Million 16.9%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.55 - $7.95 $447,563 - $641,103
-80,642 Reduced 22.3%
281,019 $2.17 Million
Q2 2024

Aug 14, 2024

SELL
$4.54 - $9.89 $2.57 Million - $5.59 Million
-565,707 Reduced 61.0%
361,661 $1.86 Million
Q1 2024

May 15, 2024

BUY
$4.03 - $8.13 $530,517 - $1.07 Million
131,642 Added 16.54%
927,368 $7.54 Million
Q4 2023

Feb 14, 2024

SELL
$3.56 - $4.65 $583,953 - $762,748
-164,032 Reduced 17.09%
795,726 $3.18 Million
Q2 2023

Aug 14, 2023

BUY
$3.06 - $6.38 $2.8 Million - $5.83 Million
914,107 Added 2002.38%
959,758 $5.7 Million
Q1 2023

May 15, 2023

SELL
$3.22 - $4.72 $21,229 - $31,118
-6,593 Reduced 12.62%
45,651 $157,000
Q4 2022

Feb 14, 2023

SELL
$3.03 - $3.79 $259,801 - $324,965
-85,743 Reduced 62.14%
52,244 $183,000
Q3 2022

Nov 14, 2022

SELL
$3.58 - $5.88 $525,157 - $862,548
-146,692 Reduced 51.53%
137,987 $500,000
Q2 2022

Aug 15, 2022

BUY
$5.13 - $9.2 $1.37 Million - $2.47 Million
267,953 Added 1602.01%
284,679 $1.6 Million
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $17,893 - $24,251
-2,071 Reduced 11.02%
16,726 $145,000
Q4 2021

Feb 14, 2022

BUY
$10.95 - $16.07 $41,467 - $60,857
3,787 Added 25.23%
18,797 $209,000
Q3 2021

Nov 15, 2021

BUY
$12.95 - $18.24 $194,379 - $273,782
15,010 New
15,010 $194,000
Q2 2021

Aug 16, 2021

SELL
$15.83 - $17.84 $159,186 - $179,399
-10,056 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$15.92 - $20.3 $160,091 - $204,136
10,056 New
10,056 $173,000
Q2 2020

Aug 14, 2020

SELL
$10.39 - $16.07 $312,188 - $482,855
-30,047 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$8.89 - $24.94 $964,653 - $2.71 Million
-108,510 Reduced 78.31%
30,047 $319,000
Q4 2019

Feb 14, 2020

BUY
$8.33 - $19.95 $1.02 Million - $2.43 Million
121,895 Added 731.57%
138,557 $2.59 Million
Q3 2019

Nov 14, 2019

BUY
$6.86 - $10.46 $35,301 - $53,827
5,146 Added 44.69%
16,662 $174,000
Q2 2019

Aug 15, 2019

SELL
$6.99 - $11.27 $12,127 - $19,553
-1,735 Reduced 13.09%
11,516 $87,000
Q2 2019

Aug 14, 2019

SELL
$6.99 - $11.27 $1.39 Million - $2.24 Million
-199,097 Reduced 93.76%
13,251 $205,000
Q1 2019

May 14, 2019

BUY
$5.05 - $11.62 $824,725 - $1.9 Million
163,312 Added 333.05%
212,348 $2.34 Million
Q4 2018

Feb 14, 2019

SELL
$3.22 - $6.27 $365,122 - $710,967
-113,392 Reduced 69.81%
49,036 $249,000
Q3 2018

Nov 14, 2018

SELL
$2.31 - $4.69 $104,735 - $212,644
-45,340 Reduced 21.82%
162,428 $517,000
Q2 2018

Aug 14, 2018

BUY
$4.04 - $5.13 $839,382 - $1.07 Million
207,768 New
207,768 $931,000
Q1 2018

May 15, 2018

SELL
$3.92 - $5.35 $85,118 - $116,169
-21,714 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.9 - $4.66 $84,684 - $101,187
21,714
21,714 $86,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $202M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.